Patents by Inventor James Daniel

James Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260000659
    Abstract: The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates and/or other forms thereof, corresponding pharmaceutical compositions, methods and/or uses of the IL-23R inhibitors for treatment of autoimmune inflammation diseases and/or related disorders.
    Type: Application
    Filed: June 24, 2025
    Publication date: January 1, 2026
    Inventors: Santhosh NEELAMKAVIL, Chengzao SUN, Sandeep SOMANI, Stephanie A. BARROS, Raymond J. PATCH, Jing ZHANG, Douglas RIEXINGER, Charles HENDRICK, Elisabetta BIANCHI, Roberto COSTANTE, Federica ROSOLIA, Martina LOLLOBRIGIDA, Sonia DEL RIZZO, Danila BRANCA, Ashok BHANDARI, James DANIEL, Tran Trung TRAN, Brian FREDERICK
  • Patent number: 12478617
    Abstract: The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates and/or other forms thereof, corresponding pharmaceutical compositions, methods and/or uses of the IL-23R inhibitors for treatment of autoimmune inflammation diseases and/or related disorders.
    Type: Grant
    Filed: October 26, 2023
    Date of Patent: November 25, 2025
    Assignees: JANSSEN BIOTECH, INC., PROTAGONIST THERAPEUTICS, INC.
    Inventors: Santhosh Neelamkavil, Chengzao Sun, Sandeep Somani, Stephanie A. Barros, Danila Branca, Ashok Bhandari, James Daniel, Tran Trung Tran, Brian Frederick
  • Publication number: 20240409598
    Abstract: The present invention relates to novel cyclic peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, methods and/or uses for treatment of autoimmune inflammation and related diseases and disorders. The inhibitor of an interleukin-23 receptor is cyclized by a disulfide bond between penicillamine, cysteine, homocysteine, or alpha methylcysteine residues at positions X4 and X9.
    Type: Application
    Filed: July 14, 2022
    Publication date: December 12, 2024
    Inventors: Stephanie A. Barros, Charles Hendrick, Santhosh Neelamkavil, Raymond J. Patch, Sandeep Somani, Chengzao Sun, Jing Zhang, Elisabetta Bianchi, Danila Branca, Roberto Costante, Raffaele Ingenito, Ashok Bhandari, Brian Frederick, James Daniel, Tran Trung Tran
  • Publication number: 20240370959
    Abstract: A web-based service that provides a range of sexual education experiences, ranging from unobjectionable to pornographic, all may be moderated by the same worker is disclosed. In the unobjectionable to pornographic segments of training, various products will be discussed and used. These products may be purchased by clicking through a link on the video training page and being taken to a product page which is constructed to match the training page in its explicitness, i.e., unobjectionable to pornographic. An alternative embodiment of the present invention features a product page which is constructed to not match the training page in its explicitness, i.e., unobjectionable to pornographic.
    Type: Application
    Filed: September 2, 2022
    Publication date: November 7, 2024
    Applicant: LL Creations LLC
    Inventors: Austin Madore, James Daniel
  • Publication number: 20240173309
    Abstract: The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates and/or other forms thereof, corresponding pharmaceutical compositions, methods and/or uses of the IL-23R inhibitors for treatment of autoimmune inflammation diseases and/or related disorders.
    Type: Application
    Filed: October 26, 2023
    Publication date: May 30, 2024
    Inventors: Santhosh NEELAMKAVIL, Chengzao SUN, Sandeep SOMANI, Stephanie A. BARROS, Raymond J. PATCH, Jing ZHANG, Douglas RIEXINGER, Charles HENDRICK, Elisabetta BIANCHI, Roberto COSTANTE, Federica ROSOLIA, Martina LOLLOBRIGIDA, Sonia DEL RIZZO, Danila BRANCA, Ashok BHANDARI, James DANIEL, Tran Trung TRAN, Brian FREDERICK
  • Publication number: 20230035040
    Abstract: An internal lining system of an industrial chimney includes a first building block and a second building block, each having a front face facing gas flowing through the industrial chimney; a joint of binding material configured to connect the first and second building blocks such that the front faces of the first and second building blocks are aligned; and a slot formed on the front face of the first building block, smoothly crossing the joint of binding material, and formed on the front face of the second building block; wherein the slot has a depth smaller than depths of the first and second building blocks.
    Type: Application
    Filed: July 28, 2022
    Publication date: February 2, 2023
    Inventors: James Daniel, F. Douglas Cochrane
  • Publication number: 20130258277
    Abstract: This invention discloses methods and apparatus for providing an ophthalmic lens with diffractive/refractive variable optic structures. An energy source is capable of powering the variable optic included within the ophthalmic lens as it may be predetermined. In some embodiments, an ophthalmic lens is cast molded from a silicone hydrogel.
    Type: Application
    Filed: April 1, 2013
    Publication date: October 3, 2013
    Applicant: Johnson & Johnson Vision Care, Inc.
    Inventors: Randall B. Pugh, Daniel B. Otts, James Daniel, C. Benjamin Wooley, Edward R. Kernick, Frederick A. Flitsch, Andres F. Arrubla
  • Patent number: 6484051
    Abstract: A Compton imager and method are provided for generating three-dimensional images. The Compton imager detects Compton scattering of simultaneously or nearly simultaneously emitted gamma rays produced by a radio-nuclide. A possible location of each radio-nuclide decay is defined by the intersection of Compton direction cones corresponding to the detected gamma rays. Three-dimensional images are generated by superposition of individual locations of separate radioactive decay locations.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: November 19, 2002
    Inventor: James Daniel